社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Joyce124
IP属地：广东
+关注
帖子 · 116
帖子 · 116
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Joyce124
Joyce124
·
08-20
疯狂的股票？还让不让人休息？睡的时候是红的，睡醒变绿了[笑哭] [笑哭] [笑哭] [笑哭] [笑哭]
港交所陈翊庭：港交所将研究24小时交易机制
8月20日，在港交所2025年中期业绩会议上，港交所集团行政总裁陈翊庭表示：“港交所在保持全球竞争力方面始终坚持战略性投入原则。港交所在资本开支方面不会吝啬，我们持续加大在数据平台优化、交易结算系统升级等方面的投入力度。”在现场，陈翊庭回答了市场热议的延长交易时间的问题。
港交所陈翊庭：港交所将研究24小时交易机制
看
114
回复
评论
点赞
1
编组 21备份 2
分享
举报
Joyce124
Joyce124
·
08-03
拉一下股价吧
植华集团(01842)发盈警 预计中期亏损净额同比扩大约40%至50%
智通财经APP讯，植华集团(01842)发布公告，与截至2024年6月30日止6个月约580万港元的亏损净额相比，集团可能于2025年上半年取得亏损净额增加约40%至50%。预期2025年上半年的亏损净额增加乃主要由于(i)2025年上半年的收益轻微下降，乃主要由于美国持续的关税相关压力;(ii)确认2025年上半年上市证券投资公平值未变现亏损约330万港元，而2024年上半年则取得亏损220万港元;及(iii)行政开支增加约190万港元，乃主要由于集团加强多元化供应链网络及推进业务发展措施所致。
植华集团(01842)发盈警 预计中期亏损净额同比扩大约40%至50%
看
250
回复
评论
点赞
1
编组 21备份 2
分享
举报
Joyce124
Joyce124
·
05-22
$植华集团(01842)$
大神带回本呗！输少我都当年了！拿了几年了[流泪] [流泪] [流泪] [流泪]
看
832
回复
评论
点赞
1
编组 21备份 2
分享
举报
Joyce124
Joyce124
·
05-09
$开拓药业-B(09939)$
好过份哦
看
787
回复
评论
点赞
1
编组 21备份 2
分享
举报
Joyce124
Joyce124
·
04-10
$开拓药业-B(09939)$
好贱！
看
660
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Joyce124
Joyce124
·
04-02
$植华集团(01842)$
回个本就这么难吗？
看
696
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Joyce124
Joyce124
·
02-16
最高峰70多块钱的！现在0.96[捂脸] [捂脸] [捂脸] [捂脸]
困境中的转机——嘉和生物与亿腾医药合并
2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。此次合并亿腾医药，将使得嘉和生物能够借助亿腾医药强大的商业化能力，将手中的创新药物更快地推向市场，实现商业化收益。当然嘉和生物与亿腾医药的合并事件也为我们留下了许多值得思考的地方：企业应该如何根据自身优势和市场环境，制定出合适的发展战略？
困境中的转机——嘉和生物与亿腾医药合并
看
1,211
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Joyce124
Joyce124
·
01-23
$植华集团(01842)$
一个股票⼀直涨是想让你买，股票⼀直跌是想要你卖！
看
998
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Joyce124
Joyce124
·
2024-09-02
$植华集团(01842)$
哎⋯⋯什么时候才回本？
看
1,884
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Joyce124
Joyce124
·
2024-06-25
$开拓药业-B(09939)$
股票就是将你的钱弄到我的口袋！
看
2,354
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3584064374196548","uuid":"3584064374196548","gmtCreate":1620971360279,"gmtModify":1620971360279,"name":"Joyce124","pinyin":"joyce124","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":7,"tweetSize":116,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.12%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-1","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识体验官","description":"观看学堂课程满5节","bigImgUrl":"https://static.tigerbbs.com/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://static.tigerbbs.com/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.39%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":6,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":469637462093904,"gmtCreate":1755688568300,"gmtModify":1755688570281,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"疯狂的股票？还让不让人休息？睡的时候是红的，睡醒变绿了[笑哭] [笑哭] [笑哭] [笑哭] [笑哭] ","listText":"疯狂的股票？还让不让人休息？睡的时候是红的，睡醒变绿了[笑哭] [笑哭] [笑哭] [笑哭] [笑哭] ","text":"疯狂的股票？还让不让人休息？睡的时候是红的，睡醒变绿了[笑哭] [笑哭] [笑哭] [笑哭] [笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469637462093904","repostId":"1151575546","repostType":4,"repost":{"id":"1151575546","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1755687905,"share":"https://www.laohu8.com/m/news/1151575546?lang=&edition=full","pubTime":"2025-08-20 19:05","market":"us","language":"zh","title":"港交所陈翊庭：港交所将研究24小时交易机制","url":"https://stock-news.laohu8.com/highlight/detail?id=1151575546","media":"老虎资讯综合","summary":"8月20日，在港交所2025年中期业绩会议上，港交所集团行政总裁陈翊庭表示：“港交所在保持全球竞争力方面始终坚持战略性投入原则。港交所在资本开支方面不会吝啬，我们持续加大在数据平台优化、交易结算系统升级等方面的投入力度。”在现场，陈翊庭回答了市场热议的延长交易时间的问题。","content":"<html><head></head><body><p style=\"text-align: start;\">8月20日，在港交所2025年中期业绩会议上，港交所集团行政总裁陈翊庭表示：“港交所在保持全球竞争力方面始终坚持战略性投入原则。</p><p style=\"text-align: start;\">港交所在资本开支方面不会吝啬，我们持续加大在数据平台优化、交易结算系统升级等方面的投入力度。”在现场，陈翊庭回答了市场热议的延长交易时间的问题。“关于交易时间延长议题，我们注意到纳斯达克拟于2026年下半年实施每周5天24小时交易机制。</p><p style=\"text-align: start;\">港交所将秉持审慎渐进原则，在充分借鉴国际同业经验的基础上，结合本地市场实际情况进行研究。该进程需待交易系统升级、风险管理体系完善及监管框架配套成熟后逐步完善。”她表示。</p><p style=\"text-align: start;\">陈翊庭表示，港交所正积极与市场参与者就缩短现货市场结算周期进行探讨，港交所的技术系统在今年年底前将可以支持T+1结算周期，但市场何时实行T+1结算需要征求多方市场参与者意见。（上海证券报）</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港交所陈翊庭：港交所将研究24小时交易机制</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港交所陈翊庭：港交所将研究24小时交易机制\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-08-20 19:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p style=\"text-align: start;\">8月20日，在港交所2025年中期业绩会议上，港交所集团行政总裁陈翊庭表示：“港交所在保持全球竞争力方面始终坚持战略性投入原则。</p><p style=\"text-align: start;\">港交所在资本开支方面不会吝啬，我们持续加大在数据平台优化、交易结算系统升级等方面的投入力度。”在现场，陈翊庭回答了市场热议的延长交易时间的问题。“关于交易时间延长议题，我们注意到纳斯达克拟于2026年下半年实施每周5天24小时交易机制。</p><p style=\"text-align: start;\">港交所将秉持审慎渐进原则，在充分借鉴国际同业经验的基础上，结合本地市场实际情况进行研究。该进程需待交易系统升级、风险管理体系完善及监管框架配套成熟后逐步完善。”她表示。</p><p style=\"text-align: start;\">陈翊庭表示，港交所正积极与市场参与者就缩短现货市场结算周期进行探讨，港交所的技术系统在今年年底前将可以支持T+1结算周期，但市场何时实行T+1结算需要征求多方市场参与者意见。（上海证券报）</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/5a0d8d07bb7c07ed67df2bae10160584","relate_stocks":{"00388":"香港交易所"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151575546","content_text":"8月20日，在港交所2025年中期业绩会议上，港交所集团行政总裁陈翊庭表示：“港交所在保持全球竞争力方面始终坚持战略性投入原则。港交所在资本开支方面不会吝啬，我们持续加大在数据平台优化、交易结算系统升级等方面的投入力度。”在现场，陈翊庭回答了市场热议的延长交易时间的问题。“关于交易时间延长议题，我们注意到纳斯达克拟于2026年下半年实施每周5天24小时交易机制。港交所将秉持审慎渐进原则，在充分借鉴国际同业经验的基础上，结合本地市场实际情况进行研究。该进程需待交易系统升级、风险管理体系完善及监管框架配套成熟后逐步完善。”她表示。陈翊庭表示，港交所正积极与市场参与者就缩短现货市场结算周期进行探讨，港交所的技术系统在今年年底前将可以支持T+1结算周期，但市场何时实行T+1结算需要征求多方市场参与者意见。（上海证券报）","news_type":1,"symbols_score_info":{"00388":1.1}},"isVote":1,"tweetType":1,"viewCount":114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":463696824193152,"gmtCreate":1754187571653,"gmtModify":1754187573305,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"拉一下股价吧","listText":"拉一下股价吧","text":"拉一下股价吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/463696824193152","repostId":"2556920892","repostType":2,"repost":{"id":"2556920892","kind":"news","pubTimestamp":1754044712,"share":"https://www.laohu8.com/m/news/2556920892?lang=&edition=full","pubTime":"2025-08-01 18:38","market":"sh","language":"zh","title":"植华集团(01842)发盈警 预计中期亏损净额同比扩大约40%至50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556920892","media":"智通财经","summary":"智通财经APP讯，植华集团(01842)发布公告，与截至2024年6月30日止6个月约580万港元的亏损净额相比，集团可能于2025年上半年取得亏损净额增加约40%至50%。预期2025年上半年的亏损净额增加乃主要由于(i)2025年上半年的收益轻微下降，乃主要由于美国持续的关税相关压力;(ii)确认2025年上半年上市证券投资公平值未变现亏损约330万港元，而2024年上半年则取得亏损220万港元;及(iii)行政开支增加约190万港元，乃主要由于集团加强多元化供应链网络及推进业务发展措施所致。","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/01842\">植华集团</a>(01842)发布公告，与截至2024年6月30日止6个月约580万港元的亏损净额相比，集团可能于2025年上半年取得亏损净额增加约40%至50%。预期2025年上半年的亏损净额增加乃主要由于(i)2025年上半年的收益轻微下降，乃主要由于美国持续的关税相关压力;(ii)确认2025年上半年上市证券投资公平值未变现亏损约330万港元，而2024年上半年则取得亏损220万港元;及(iii)行政开支增加约190万港元，乃主要由于集团加强多元化供应链网络及推进业务发展措施所致。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>植华集团(01842)发盈警 预计中期亏损净额同比扩大约40%至50%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n植华集团(01842)发盈警 预计中期亏损净额同比扩大约40%至50%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-01 18:38 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/1324885.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，植华集团(01842)发布公告，与截至2024年6月30日止6个月约580万港元的亏损净额相比，集团可能于2025年上半年取得亏损净额增加约40%至50%。预期2025年上半年的亏损净额增加乃主要由于(i)2025年上半年的收益轻微下降，乃主要由于美国持续的关税相关压力;(ii)确认2025年上半年上市证券投资公平值未变现亏损约330万港元，而2024年上半年则取得亏损220...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1324885.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1227":"服装、服饰与奢侈品","01842":"植华集团"},"source_url":"http://www.zhitongcaijing.com/content/detail/1324885.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2556920892","content_text":"智通财经APP讯，植华集团(01842)发布公告，与截至2024年6月30日止6个月约580万港元的亏损净额相比，集团可能于2025年上半年取得亏损净额增加约40%至50%。预期2025年上半年的亏损净额增加乃主要由于(i)2025年上半年的收益轻微下降，乃主要由于美国持续的关税相关压力;(ii)确认2025年上半年上市证券投资公平值未变现亏损约330万港元，而2024年上半年则取得亏损220万港元;及(iii)行政开支增加约190万港元，乃主要由于集团加强多元化供应链网络及推进业务发展措施所致。","news_type":1,"symbols_score_info":{"01842":1}},"isVote":1,"tweetType":1,"viewCount":250,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":437631030759992,"gmtCreate":1747874172665,"gmtModify":1747878113662,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 大神带回本呗！输少我都当年了！拿了几年了[流泪] [流泪] [流泪] [流泪] ","listText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 大神带回本呗！输少我都当年了！拿了几年了[流泪] [流泪] [流泪] [流泪] ","text":"$植华集团(01842)$ 大神带回本呗！输少我都当年了！拿了几年了[流泪] [流泪] [流泪] [流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/437631030759992","isVote":1,"tweetType":1,"viewCount":832,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":433056947356104,"gmtCreate":1746760220874,"gmtModify":1746760222233,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好过份哦","listText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好过份哦","text":"$开拓药业-B(09939)$ 好过份哦","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/433056947356104","isVote":1,"tweetType":1,"viewCount":787,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":423069229441320,"gmtCreate":1744256665732,"gmtModify":1744258381447,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好贱！","listText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好贱！","text":"$开拓药业-B(09939)$ 好贱！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/423069229441320","isVote":1,"tweetType":1,"viewCount":660,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":419969055334776,"gmtCreate":1743562729969,"gmtModify":1743563375655,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 回个本就这么难吗？","listText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 回个本就这么难吗？","text":"$植华集团(01842)$ 回个本就这么难吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/419969055334776","isVote":1,"tweetType":1,"viewCount":696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":404115656814792,"gmtCreate":1739685752994,"gmtModify":1739685754889,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"最高峰70多块钱的！现在0.96[捂脸] [捂脸] [捂脸] [捂脸] ","listText":"最高峰70多块钱的！现在0.96[捂脸] [捂脸] [捂脸] [捂脸] ","text":"最高峰70多块钱的！现在0.96[捂脸] [捂脸] [捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/404115656814792","repostId":"2511638680","repostType":2,"repost":{"id":"2511638680","kind":"news","pubTimestamp":1739505882,"share":"https://www.laohu8.com/m/news/2511638680?lang=&edition=full","pubTime":"2025-02-14 12:04","market":"hk","language":"zh","title":"困境中的转机——嘉和生物与亿腾医药合并","url":"https://stock-news.laohu8.com/highlight/detail?id=2511638680","media":"新浪财经","summary":"2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。此次合并亿腾医药，将使得嘉和生物能够借助亿腾医药强大的商业化能力，将手中的创新药物更快地推向市场，实现商业化收益。当然嘉和生物与亿腾医药的合并事件也为我们留下了许多值得思考的地方：企业应该如何根据自身优势和市场环境，制定出合适的发展战略？","content":"<html><body><article><p>在 生物医药 领域融资困境持续存在的背景下，本土biotech企业迎来了一场引人注目的大型并购案。2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。</p><p>此次并购事件堪称业界瞩目的现象级交易。嘉和生物的研发能力和具有潜力的产品管线一直备受瞩目。而亿腾医药也以其出色的商业化能力和稳定的现金流在业界占有一席之地。此次并购将使双方 优势资源 进行深度融合与高效整合，为中国 创新药 企开辟了一条全新且具有潜力的发展路径。</p><p>亿腾医药的上市之路遭遇挑战，面对当前IPO市场表现持续低迷的困境，亿腾医药选择通过嘉和生物进行“借壳上市”，无疑是一个深思熟虑且明智的战略部署。此举旨在加速企业进军 资本市场 的步伐，同时为公司开辟更为广阔的融资渠道，并为其后续发展创造更大的空间和机遇。</p><p>嘉和生物虽然曾在2020年成功实现IPO，但近年来却面临着新品研发慢人一步、PD-1上市被否、裁员等困境。然而，其手中的众多潜力靶点和创新管线仍具有巨大的价值。此次合并亿腾医药，将使得嘉和生物能够借助亿腾医药强大的商业化能力，将手中的创新药物更快地推向市场，实现商业化收益。</p><p>合并后的新公司亿腾嘉和未来的发展模式将更加注重海内外资源的整合与利用。在拓展中国商业化发展的同时，通过包括NewCo模式等的出海方式布局海外市场，寻求新增量空间。这种发展模式不仅有助于提升企业的国际竞争力，还将为中国创新药企的全球化发展探索出一条新的路径。</p><p>此次并购事件将是港股18A公司交易活动启动的预示，同时也为当前仍在积极寻求发展路径的部分药企开辟了新的思路与方向。在生物医药领域，创新药物研发具有独特的魅力，时常在业界预期之外的地方绽放出新的希望与活力。正是这种不可预测性，促使着众多企业与投资者络绎不绝地投身其中，不断追寻着前行的动力与机遇。</p><p>当然嘉和生物与亿腾医药的合并事件也为我们留下了许多值得思考的地方：企业应该如何根据自身优势和市场环境，制定出合适的发展战略？如何实现企业的可 持续发展 ？这些问题都需要企业不断探索。</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>困境中的转机——嘉和生物与亿腾医药合并</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n困境中的转机——嘉和生物与亿腾医药合并\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-14 12:04 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214122036abce64bf&s=b><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>在 生物医药 领域融资困境持续存在的背景下，本土biotech企业迎来了一场引人注目的大型并购案。2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。此次并购事件堪称业界瞩目的现象级交易。嘉和生物的研发能力和具有潜力的产品管线一直备受瞩目。而亿腾医药也以其出色的商业化能力和稳定的现金流在业界占有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214122036abce64bf&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1161":"生物科技","BK1574":"生物医药B类股","09939":"开拓药业-B","BK1583":"高瓴概念","06998":"嘉和生物-B","BK1515":"抗疫概念"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214122036abce64bf&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2511638680","content_text":"在 生物医药 领域融资困境持续存在的背景下，本土biotech企业迎来了一场引人注目的大型并购案。2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。此次并购事件堪称业界瞩目的现象级交易。嘉和生物的研发能力和具有潜力的产品管线一直备受瞩目。而亿腾医药也以其出色的商业化能力和稳定的现金流在业界占有一席之地。此次并购将使双方 优势资源 进行深度融合与高效整合，为中国 创新药 企开辟了一条全新且具有潜力的发展路径。亿腾医药的上市之路遭遇挑战，面对当前IPO市场表现持续低迷的困境，亿腾医药选择通过嘉和生物进行“借壳上市”，无疑是一个深思熟虑且明智的战略部署。此举旨在加速企业进军 资本市场 的步伐，同时为公司开辟更为广阔的融资渠道，并为其后续发展创造更大的空间和机遇。嘉和生物虽然曾在2020年成功实现IPO，但近年来却面临着新品研发慢人一步、PD-1上市被否、裁员等困境。然而，其手中的众多潜力靶点和创新管线仍具有巨大的价值。此次合并亿腾医药，将使得嘉和生物能够借助亿腾医药强大的商业化能力，将手中的创新药物更快地推向市场，实现商业化收益。合并后的新公司亿腾嘉和未来的发展模式将更加注重海内外资源的整合与利用。在拓展中国商业化发展的同时，通过包括NewCo模式等的出海方式布局海外市场，寻求新增量空间。这种发展模式不仅有助于提升企业的国际竞争力，还将为中国创新药企的全球化发展探索出一条新的路径。此次并购事件将是港股18A公司交易活动启动的预示，同时也为当前仍在积极寻求发展路径的部分药企开辟了新的思路与方向。在生物医药领域，创新药物研发具有独特的魅力，时常在业界预期之外的地方绽放出新的希望与活力。正是这种不可预测性，促使着众多企业与投资者络绎不绝地投身其中，不断追寻着前行的动力与机遇。当然嘉和生物与亿腾医药的合并事件也为我们留下了许多值得思考的地方：企业应该如何根据自身优势和市场环境，制定出合适的发展战略？如何实现企业的可 持续发展 ？这些问题都需要企业不断探索。","news_type":1,"symbols_score_info":{"06998":1,"09939":1}},"isVote":1,"tweetType":1,"viewCount":1211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":395561982677680,"gmtCreate":1737600699445,"gmtModify":1737602077180,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 一个股票⼀直涨是想让你买，股票⼀直跌是想要你卖！","listText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 一个股票⼀直涨是想让你买，股票⼀直跌是想要你卖！","text":"$植华集团(01842)$ 一个股票⼀直涨是想让你买，股票⼀直跌是想要你卖！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/395561982677680","isVote":1,"tweetType":1,"viewCount":998,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":345061094244536,"gmtCreate":1725270287140,"gmtModify":1725270387747,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 哎⋯⋯什么时候才回本？","listText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 哎⋯⋯什么时候才回本？","text":"$植华集团(01842)$ 哎⋯⋯什么时候才回本？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345061094244536","isVote":1,"tweetType":1,"viewCount":1884,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":320534808531088,"gmtCreate":1719288448579,"gmtModify":1719288450127,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584064374196548","idStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 股票就是将你的钱弄到我的口袋！","listText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 股票就是将你的钱弄到我的口袋！","text":"$开拓药业-B(09939)$ 股票就是将你的钱弄到我的口袋！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/320534808531088","isVote":1,"tweetType":1,"viewCount":2354,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}